Henry Lopez

1.0k total citations
9 papers, 309 citations indexed

About

Henry Lopez is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Henry Lopez has authored 9 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Henry Lopez's work include Systemic Sclerosis and Related Diseases (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Dermatologic Treatments and Research (2 papers). Henry Lopez is often cited by papers focused on Systemic Sclerosis and Related Diseases (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Dermatologic Treatments and Research (2 papers). Henry Lopez collaborates with scholars based in United States, United Kingdom and Bangladesh. Henry Lopez's co-authors include Patricia D. Williams, Alan M. Ezrin, Deborah Britt, Christine Chan, Francine M. Gregoire, Qin Zhang, Carmen H. Tong, Steven J. Smith, David A. Ross and David B. West and has published in prestigious journals such as Scientific Reports, American Journal of Physiology-Endocrinology and Metabolism and Lara D. Veeken.

In The Last Decade

Henry Lopez

9 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry Lopez United States 6 93 78 63 56 49 9 309
Kurt Gleich Australia 11 172 1.8× 47 0.6× 62 1.0× 40 0.7× 77 1.6× 16 339
Patsy Carter United States 8 108 1.2× 85 1.1× 45 0.7× 27 0.5× 74 1.5× 11 351
Wenyuan Guo China 14 180 1.9× 42 0.5× 39 0.6× 85 1.5× 101 2.1× 39 543
Amar Kapoor United Kingdom 12 211 2.3× 45 0.6× 57 0.9× 78 1.4× 57 1.2× 14 480
Daniele Moraes Losada Brazil 5 107 1.2× 83 1.1× 30 0.5× 29 0.5× 101 2.1× 10 328
Nerimiah Emmett United States 11 170 1.8× 67 0.9× 44 0.7× 32 0.6× 72 1.5× 20 441
Chakradhar Velagapudi United States 8 254 2.7× 38 0.5× 72 1.1× 50 0.9× 51 1.0× 11 463
Mingfeng Cao China 12 134 1.4× 41 0.5× 74 1.2× 116 2.1× 23 0.5× 21 353
Hengdao Liu China 12 183 2.0× 32 0.4× 51 0.8× 72 1.3× 74 1.5× 26 399
Yu Lin China 11 191 2.1× 31 0.4× 95 1.5× 43 0.8× 51 1.0× 23 445

Countries citing papers authored by Henry Lopez

Since Specialization
Citations

This map shows the geographic impact of Henry Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Lopez more than expected).

Fields of papers citing papers by Henry Lopez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Lopez. The network helps show where Henry Lopez may publish in the future.

Co-authorship network of co-authors of Henry Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Lopez. A scholar is included among the top collaborators of Henry Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Lopez. Henry Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ghebremedhin, Anghesom, Ahmad Bin Salam, Richard Stratton, et al.. (2023). A Novel CD206 Targeting Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice. Cells. 12(9). 1254–1254. 16 indexed citations
2.
Salam, Ahmad Bin, Clayton Yates, Jesse M. Jaynes, et al.. (2023). Evaluation of a CD206-Targeted Peptide for PET Imaging of Macrophages in Syngeneic Mouse Models of Cancer. Molecular Pharmaceutics. 20(5). 2415–2425. 12 indexed citations
3.
Coumbe, Ben G T, Henry Lopez, Charles Garvin, et al.. (2021). P155 Modelling calcinosis in systemic sclerosis through disease microenvironment-stem cell interactions: effect of novel therapeutic peptide RP832c. Lara D. Veeken. 60(Supplement_1). 1 indexed citations
4.
Thilly, William G., Henry Lopez, Amy C. Hart, et al.. (2020). Pathogenic Activation of Mesenchymal Stem Cells Is Induced by the Disease Microenvironment in Systemic Sclerosis. Arthritis & Rheumatology. 72(8). 1361–1374. 29 indexed citations
5.
Lopez, Henry, Elisabetta Renzoni, Athol U. Wells, et al.. (2017). Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration. Scientific Reports. 7(1). 2628–2628. 3 indexed citations
6.
Clark, Kristina E N, Henry Lopez, Sandra G. Guerra, et al.. (2015). Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis. Arthritis Research & Therapy. 17(1). 73–73. 21 indexed citations
7.
Dietrich, Jennifer E., et al.. (2004). A case of poorly differentiated Sertoli-Leydig tumor of the ovary. Journal of Pediatric and Adolescent Gynecology. 17(1). 49–52. 3 indexed citations
8.
Gregoire, Francine M., Qin Zhang, Steven J. Smith, et al.. (2002). Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. American Journal of Physiology-Endocrinology and Metabolism. 282(3). E703–E713. 99 indexed citations
9.
Williams, Patricia D., et al.. (1997). Characterization of renal ischemia-reperfusion injury in rats. Journal of Pharmacological and Toxicological Methods. 37(1). 1–7. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026